Brief: Annexon To Report Archer Phase 2 Trial Results In Geographic Atrophy At ASRS 2023
24/07/2023 11:36
July 24 (Reuters) - Annexon Inc ANNX.O :
* ANNEXON TO REPORT ARCHER PHASE 2 TRIAL RESULTS IN
GEOGRAPHIC
ATROPHY AT ASRS 2023
Source text for Eikon: ID:nGNX5DLSRh
Further company coverage: ANNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Annexon
See all newsBrief: Annexon Reports Inducement Grants to New Employees
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Annexon, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte